Lifecore Biomedical, Inc.
LFCR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001005286
No open-market purchases or sales by Lifecore Biomedical, Inc. insiders were filed in the last 90 days; 98 institutions reported holding it in 13F filings for Q2 2026, worth $133.3M in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding Lifecore Biomedical, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 82 | 75 | −7 |
| Shares | 22.7M | 19.9M | −2.80M (−12.3%) |
| Value | $81.7M | $173.9M | +$92.2M (+112.8%) |
New holders (19)
Institutions that held Lifecore Biomedical, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Millennium Management LLC | 375,622 | $3.63M | 0.00% |
| Marshall Wace, LLP | 127,067 | $1.23M | 0.00% |
| Jane Street Group, LLC | 94,950 | $918.2K | 0.00% |
| DCF Advisers, LLC | 87,500 | $846.1K | 0.58% |
| Citadel Advisors LLC | 68,406 | $661.5K | 0.00% |
| Ergoteles LLC | 51,100 | $494.1K | 0.02% |
| HRT Financial LP | 28,459 | $275.0K | 0.00% |
| Qube Research & Technologies Ltd | 27,911 | $269.9K | 0.00% |
| Y-Intercept (Hong Kong) Ltd | 26,258 | $253.9K | 0.03% |
| Squarepoint Ops LLC | 23,657 | $228.8K | 0.00% |
| Old Mission Capital LLC | 21,505 | $208.0K | 0.01% |
| PEAK6 Investments LLC | 18,524 | $179.1K | 0.02% |
| Engineers Gate Manager LP | 17,906 | $173.2K | 0.01% |
| American Century Companies Inc | 15,578 | $150.6K | 0.00% |
| Mirabella Financial Services LLP | 15,413 | $149.0K | 0.02% |
| Laurion Capital Management LP | 14,405 | $139.3K | 0.01% |
| Cubist Systematic Strategies, LLC | 10,538 | $101.9K | 0.00% |
| Parallel Advisors, LLC | 225 | $2.18K | 0.00% |
| Nisa Investment Advisors, LLC | 28 | $271 | 0.00% |
Sold out (26)
Institutions that held Lifecore Biomedical, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.